Literature DB >> 22818386

Differential expression of vascular endothelial growth factor isoforms and receptor subtypes in the infarcted heart.

Tieqiang Zhao1, Wenyuan Zhao, Yuanjian Chen, Li Liu, Robert A Ahokas, Yao Sun.   

Abstract

AIMS: The vascular endothelial growth factor (VEGF) family contains four major isoforms and three receptor subtypes. The expressions of each VEGF isoform and receptor subtype in cardiac repair/remodeling after myocardial infarction (MI) remain uncertain and are investigated in the current study. METHODS AND
RESULTS: Temporal and spatial expressions of VEGF isoforms and VEGFR subtypes were examined in the infarcted rat heart. Sham-operated rats served as controls. We found that the normal myocardium expressed all VEGF isoforms. Following MI, VEGF-A was only increased in the border zone at day 1 and was significantly decreased in the infarcted heart during the 42 day observation period afterwards. VEGF-B was significantly suppressed in the infarcted heart. VEGF-C and VEGF-D were markedly increased in the infarcted heart in both early and late stages of MI. VEGFR-1 and 2 were significantly decreased in the infarcted heart, while VEGFR-3 was significantly increased, which was primarily expressed in blood vessels and myofibroblasts (myoFb).
CONCLUSIONS: VEGF isoforms and VEGFR subtypes are differentially expressed in the infarcted heart. Increased VEGF-A in the very early stage of MI suggests the potential role in initiating the cardiac angiogenic response. Suppressed cardiac VEGF-B postMI suggests that it may not be critical to cardiac repair. The presence of enhanced VEGF-C and VEGF-D along with its receptor, VEGFR-3, in various cell types of the infarcted heart suggest that these isoforms may regulate multiple responses during cardiac repair/remodeling.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac repair/remodeling; Myocardial infarction; VEGF isoforms; VEGF receptor subtypes

Mesh:

Substances:

Year:  2012        PMID: 22818386      PMCID: PMC3714340          DOI: 10.1016/j.ijcard.2012.06.127

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  30 in total

Review 1.  VEGF as a key mediator of angiogenesis in cancer.

Authors:  Peter Carmeliet
Journal:  Oncology       Date:  2005-11-21       Impact factor: 2.935

2.  Vascular endothelial growth factor-C accelerates diabetic wound healing.

Authors:  Anne Saaristo; Tuomas Tammela; Anniina Farkkilā; Marika Kärkkäinen; Erkki Suominen; Seppo Yla-Herttuala; Kari Alitalo
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

3.  Vascular endothelial growth factor (VEGF)-A: role on cardiac angiogenesis following myocardial infarction.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Yuanjian Chen; Robert A Ahokas; Yao Sun
Journal:  Microvasc Res       Date:  2010-04-01       Impact factor: 3.514

4.  Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in hepatocellular carcinoma cells.

Authors:  Zeng Yong Yi; Liu Jing Feng; Zhang Xiang; Huang Yao
Journal:  J Invest Surg       Date:  2011       Impact factor: 2.533

5.  Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart.

Authors:  Y Sun; K T Weber
Journal:  J Mol Cell Cardiol       Date:  1996-05       Impact factor: 5.000

6.  Expression of vascular endothelial growth factor D is associated with hypoxia inducible factor (HIF-1alpha) and the HIF-1alpha target gene DEC1, but not lymph node metastasis in primary human breast carcinomas.

Authors:  M J Currie; V Hanrahan; S P Gunningham; H R Morrin; C Frampton; C Han; B A Robinson; S B Fox
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

7.  VEGF-D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma.

Authors:  Armin Thelen; Arne Scholz; Christoph Benckert; Zofia von Marschall; Maik Schröder; Bertram Wiedenmann; Peter Neuhaus; Stefan Rosewicz; Sven Jonas
Journal:  Int J Cancer       Date:  2008-06-01       Impact factor: 7.396

8.  Cardiac oxidative stress and remodeling following infarction: role of NADPH oxidase.

Authors:  Wenyuan Zhao; Dawn Zhao; Ran Yan; Yao Sun
Journal:  Cardiovasc Pathol       Date:  2008-03-04       Impact factor: 2.185

Review 9.  [Cardiac remodeling and inflammation].

Authors:  Martín Martínez Rosas
Journal:  Arch Cardiol Mex       Date:  2006 Oct-Dec

Review 10.  Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition.

Authors:  Katherine Holmes; Owain Ll Roberts; Angharad M Thomas; Michael J Cross
Journal:  Cell Signal       Date:  2007-06-12       Impact factor: 4.315

View more
  21 in total

1.  VEGF-C/VEGFR-3 pathway promotes myocyte hypertrophy and survival in the infarcted myocardium.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Ivan C Gerling; Karl T Weber; Syamal K Bhattacharya; Rahul Kumar; Yao Sun
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

2.  Defining the molecular signatures of human right heart failure.

Authors:  Jordan L Williams; Omer Cavus; Emefah C Loccoh; Sara Adelman; John C Daugherty; Sakima A Smith; Benjamin Canan; Paul M L Janssen; Sara Koenig; Crystal F Kline; Peter J Mohler; Elisa A Bradley
Journal:  Life Sci       Date:  2018-01-31       Impact factor: 5.037

Review 3.  Molecular tissue changes in early myocardial ischemia: from pathophysiology to the identification of new diagnostic markers.

Authors:  Aleksandra Aljakna; Tony Fracasso; Sara Sabatasso
Journal:  Int J Legal Med       Date:  2018-01-23       Impact factor: 2.686

4.  Vascular endothelial growth factor-D mediates fibrogenic response in myofibroblasts.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Syamal K Bhattacharya; Yao Sun
Journal:  Mol Cell Biochem       Date:  2016-01-02       Impact factor: 3.396

5.  Vascular endothelial growth factor-C: its unrevealed role in fibrogenesis.

Authors:  Tieqiang Zhao; Wenyuan Zhao; Weixin Meng; Chang Liu; Yuanjian Chen; Yao Sun
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-24       Impact factor: 4.733

6.  Vascular endothelial growth factor-C protects heart from ischemia/reperfusion injury by inhibiting cardiomyocyte apoptosis.

Authors:  Xu-guang Chen; Yan-xia Lv; Dan Zhao; Lei Zhang; Fei Zheng; Jian-Ye Yang; Xiao-lin Li; Lu Wang; Lin-Yun Guo; Ya-mu Pan; Yu-wen Yan; Shi-You Chen; Jia-Ning Wang; Jun-Ming Tang; Yu Wan
Journal:  Mol Cell Biochem       Date:  2016-01-14       Impact factor: 3.396

7.  Biomarker profile in stable Fontan patients.

Authors:  Anita Saraf; Christine De Staercke; Ian Everitt; Alice Haouzi; Yi-An Ko; Staci Jennings; Jonathan H Kim; Fred H Rodriguez; Andreas P Kalogeropoulos; Arshed Quyyumi; Wendy Book
Journal:  Int J Cardiol       Date:  2020-01-09       Impact factor: 4.164

8.  Effects of mir-21 on Cardiac Microvascular Endothelial Cells After Acute Myocardial Infarction in Rats: Role of Phosphatase and Tensin Homolog (PTEN)/Vascular Endothelial Growth Factor (VEGF) Signal Pathway.

Authors:  Feng Yang; Wenwei Liu; Xiaojuan Yan; Hanyun Zhou; Hongshen Zhang; Jianfei Liu; Ming Yu; Xiaoshan Zhu; Kezhong Ma
Journal:  Med Sci Monit       Date:  2016-10-06

9.  Phenotypically heterogeneous podoplanin-expressing cell populations are associated with the lymphatic vessel growth and fibrogenic responses in the acutely and chronically infarcted myocardium.

Authors:  Maria Cimini; Antonio Cannatá; Gianandrea Pasquinelli; Marcello Rota; Polina Goichberg
Journal:  PLoS One       Date:  2017-03-23       Impact factor: 3.240

10.  Dual effects of VEGF-B on activating cardiomyocytes and cardiac stem cells to protect the heart against short- and long-term ischemia-reperfusion injury.

Authors:  Guo-Hua Li; Bin Luo; Yan-Xia Lv; Fei Zheng; Lu Wang; Meng-Xi Wei; Xian-Yu Li; Lei Zhang; Jia-Ning Wang; Shi-You Chen; Jun-Ming Tang; Xiaohua He
Journal:  J Transl Med       Date:  2016-05-04       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.